Quality of Life in Daxas-treated Patients Older Than 18 Years With severe Chronic obstructive pulmonary disease (COPD) (DACOTA) - DACOTA

Study identifier:RO-2455-401-DE

ClinicalTrials.gov identifier:NCT01285167

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Daxas for COPD therapy (DACOTA)

Medical condition

Chronic Obstructive Pulmonary Disease

Phase

-

Healthy volunteers

No

Study drug

Daxas

Sex

All

Actual Enrollment

3645

Study type

Observational

Age

18 Years +

Date

Study Start Date: 01 Aug 2010
Primary Completion Date: 01 Feb 2012
Study Completion Date: 01 Feb 2012

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Sept 2016 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria